Cardiovascular Week articles from September 2004

Cardiovascular Week archives from September 2004

Atherosclerotic lesions alter fluid mechanics in arteries.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Atheroma development alters fluid mechanics in porcine femoral arteries. According to a study from the United States, "Although the relationship between the local wall shear stresses (WSS) and...

Remnant lipoprotein concentrations raise risk of restenosis after PCI.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Postprandial increase in remnant-like cholesterol particle concentrations is an independent risk factor for restenosis after successful percutaneous coronary intervention (PCI), researchers say. ...

Natriuretic peptides are useful in diagnosing carcinoid heart disease.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Patients with carcinoid heart disease who have normal levels of natriuretic peptide (NT-proBNP) have better survival rates than those with elevated levels. According to published research from th...

Combination drug therapy for dyslipidemia may be better than monotherapy.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Combination drug therapy for dyslipidemia may be better than monotherapy. According to recent research from the United States, "Low-density lipoprotein (LDL) cholesterol reduction with statin...

ERT does not affect ischemic preconditioning in isolated rat hearts.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Estrogen replacement therapy does not affect ischemic preconditioning in isolated rat hearts, report pharmacologists in China. W.J. Peng and colleagues "tested the effects of long-term estrogen...

Better treatments are available for pulmonary arterial hypertension in children.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- New medications and the option of transplantation make treatment of pulmonary arterial hypertension in children more effective. "Pulmonary arterial hypertension is a serious progressive condition...

Patients with non-Q-wave myocardial infarction had worse outcomes at 1 year.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Patients with non-Q-wave myocardial infarction had worse outcomes at 1 year. Researchers from Canada explained "The objective of this study was to determine the management and outcome of fewer...

Cancer drug Avastin use increases risk of stroke, heart attack.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The U.S. government and Genentech are warning doctors that Avastin, used to treat colorectal cancer, increases patients' risk of heart ailments, including chest pain, strokes, ministrokes and heart...

Company gets guidance from FDA on percutaneous procedure.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- CardioGenesis Corporation (CGCP), developer of surgical products and accessories used in angina-relieving Transmyocardial Revascularization (TMR) and Percutaneous Myocardial Revascularization (PMR)...

Effects of shear flow on LDL are different than on and acetylated LDL.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers have examined the effects of a shear flow on the uptake of LDL and acetylated LDL by an EC monoculture and an EC-SMC coculture. According to a report from Japan, "To elucidate the...

Snake venom reveals clues about heart drug.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- With the help of snake venom and sophisticated laboratory testing, scientists believe they've uncovered the reason why a group of new heart medications was doing some patients more harm than good. ...

SEM analysis used to characterize aortic medial cysts.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Scanning electron microscopy has been used to elucidate the structural features of aortic ascending dilatation. "The study of cystic cavities and collagen fiber fragmentation is useful for a better...

The interior heart chamber is reconstructed from a set of data points.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Reconstructing the heart enables researchers to find geometries of the damaged muscle areas that may be dangerous. According to a study from Poland, "Adequate description of heart muscle electrical...

Long-term angiotensin II type I receptor antagonism improves coronary vasomotion.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Flow-mediated dilation (FMD) changes resulting from long-term angiotensin II type I receptor antagonism treatment seem to be a predictor of coronary circulation improvement, researchers say. ...

Endothelin-1 may be related to atherosclerosis in myocardial bridging.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Endothelin-1 may be related to atherosclerosis in myocardial bridging. According to published research from Turkey, "MB is associated with clinical and metabolic evidence of ischemia. In the present...

Stage of heart disease at start of HRT may thwart beneficial effect.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- What appears to be increased risk of cardiovascular events in women taking hormone replacement therapy, as seen in clinical trials, may actually reflect the stage of the participants' disease when they...

Statins prevent vascular effects of atherogenic lipids.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Statins have a beneficial effect on the proliferation of human endothelial cells induced by oxidized low-density lipoprotein (oxLDL) and lysophosphatidylcholine (LPC). According to recent research...

Stress tests may miss latent heart disease: additional screening helpful.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers at Cedars-Sinai Medical Center have found that stress tests may not adequately screen for latent atherosclerosis, the leading cause of heart disease. Their findings, published in the...

Medical technology achieves 94% efficiency in treating atrial fibrillation.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- CryoCor, Inc., announced 94% acute efficacy for isolation of treated pulmonary veins from Robert H. Hoyt, MD, one of its principle investigators from the Iowa Heart Center in Des Moines, using CryoCor's...

Researchers develop a new in vivo atrial fibrillation model in rats.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Newly developed rat model of atrial fibrillation (AF) has several characteristics in common with humans. "Nonpharmacological in vivo models of atrial fibrillation (AF) have been developed in large...

Preconditioning of porcine aortic valves required to generate reliable data.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Stress relaxation preconditioning of porcine aortic valves has been found to be a valuable step in tensile testing. Scientists writing in the journal Annals of Biomedical Engineering report, "In...

Faster oscillometric manometry remains accurate.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Study finds that shortening the oscillometric measurement time to approximately 60% of the original time does not affect the accuracy of blood pressure measurement. "Faster oscillometry enables one...

Subcutaneous obesity is not associated with sympathetic neural activation.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Subcutaneous obesity is not associated with sympathetic neural activation. According to published research from the United States, "We tested the hypothesis that muscle sympathetic nerve activity...

Trastuzumab-related cardiotoxicity characterized.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Trastuzumab-associated cardiotoxicity has been characterized in breast cancer patients. "Trastuzumab (Herceptin) is a humanized monoclonal antibody that specifically targets HER2-positive breast...

Cardio-devices company prices its IPO common stock offering at $8 per share.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Stereotaxis, Inc. (STXS) announced the pricing of its initial public offering (IPO) of 5,500,000 shares of its common stock at a price of $8.00 per share. All shares are being offered by Stereotaxis....

Cardiac device maker reports finances, business plan.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- CardioTech International, Inc., reports revenue of $5,531,000 for the quarter ended June 30, 2004. For the 3 months ended June 30, 2004, the company generated $73,000 of income from operations,...

Klein Biomedical Consultants ranks ultrasound companies by revenues.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Total U.S. medical ultrasound revenues reached $1.23 billion in 2003, which included a gain in market share for Siemens Medical Solutions Ultrasound Division in the echocardiography market to 31.4%,...

Pharma company reports successful results for the second quarter 2004.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- NitroMed, Inc., (NASDAQ: NTMD) reported financial results for the second quarter ended June 30, 2004. The company also reported on recent corporate achievements, including the early halt to its...

Stent maker discusses Q2, reports increased revenues.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Endologix, Inc., (ELGX), announced financial results for the second quarter ended June 30, 2004. Paul McCormick, Endologix's president and CEO, said, "During the second quarter, we continued to...

AEDs deployed in public areas doubles survival after cardiac arrest, study shows.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Cardiac Science, Inc. (DFIB), a manufacturer of automated public access defibrillators (AEDs), announced that a landmark study published in the New England Journal of Medicine found that deploying AEDs...

Postgraduate drug education and generic drugs necessary to reduce health costs.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Postgraduate drug education and investigations involving generic drugs will be necessary to actually reduce healthcare costs. According to published research from the United States, "The...

Intrapericardial drug delivery may be superior to intravenous route.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Intrapericardial (IPC) delivery of drugs to the heart may allow higher drug efficiencies with lesser side effects, researchers say. "Targeting drugs to the heart by intrapericardial (IPC) delivery...

Human cardiac fibroblasts respond to angiotensin I and II.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Human cardiac fibroblasts respond to angiotensin I and II. "The vasoactive peptide angiotensin II (Ang II) has been implicated as a mediator of myocardial fibrosis. We carried out a comparative...

RV long-axis function is related to LV systolic function.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Study finds that a decrease in left ventricular (LV) systolic function is accompanied by a decrease in both systolic and diastolic right ventricular (RV) long-axis function. According to a study...

Real-time myocardial border tracking for echocardiography is effective.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Real-time myocardial border tracking for echocardiography is effective. "Ultrasound is a main noninvasive modality for the assessment of the heart function. Wall tracking from ultrasound data is,...

Systolic atrioventricular plane displacement is a new accurate method.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Systolic atrioventricular plane displacement (AVPD) is a new method for measuring AVPD to assess ventricular systolic function and is more accuate than the traditional method, total AVPD, researchers...

FDA approves extension of expiration date for stent system.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approved extending the shelf life of a coronary stent system produced by Boston Scientific Corp., the company announced. The approval adds another 3...

Heart attacks without chest pain more often fatal.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- People who have heart attacks or other heart conditions who do not experience chest pain are commonly overlooked and undertreated at the hospital, often resulting in greater fatality rates in this group...

University of Kentucky cardiologist to lead national drug study.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A University of Kentucky (UK) cardiologist will lead a $35 million drug study involving about 8,000 patients and 200 hospitals nationally. About 40 to 80 patients will take part at UK Hospital. Dr....

Abnormal CFV related to septal thickness rather than degree of obstruction.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Abnormal coronary flow velocities are related to septal thickness rather than degree of obstruction. According to recent research published in the Journal of the American Society of...

Adenosine plays an important role in coronary syndromes and interventions.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Adenosine is an important drug for diagnosing and treating diseases of the cardiovascular system. According to recent research published in the journal Catheterization and Cardiovascular...

Healthy behaviors are the foundation of combating the aging process.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Adopting a healthy lifestyle may be the best approach to cardiovascular health, instead of vitamins, antioxidants, or hormone therapy. "The bases of "anti-aging" therapy are smoking cessation, diet...

Overlapping stents can effectively treat extracranial carotid diseases.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Overlapping stents are a safe and effective treatment for extracranial carotid diseases. "Various diseases of the carotid artery are treatable by stenting. However, few reports of overlapping...

Radiation and drug-eluting stents can prevent restenosis.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Recent research has shown that drug-eluting stents can markedly reduce the likelihood of restenosis. "Based on recent advances, this article aims to review the biological basis for the use of...

Surgery is usually inappropriate for asymptomatic carotid artery stenosis.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Unless the internal carotid artery diameter is reduced more than 80%, carotid endarterectomy should probably not be performed. "Internal carotid artery stenosis (ICAS) is responsible for...

FDA approves of Avastin manufacturing at Vacaville, California, facility.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Genentech, Inc., (DNA) announced that the U.S. Food and Drug Administration (FDA) approved the supplemental biologics license application for the manufacturing of Avastin (bevacizumab) bulk drug...

Tennessee hospital granted designation of Accredited Chest Pain Center.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The Society of Chest Pain Centers has granted the designation of Accredited Chest Pain Center to Memorial North Park Hospital, the first facility in Hixson, Tennessee, to be accredited and the 54th in...

Annual meeting focused on high cholesterol guidelines and therapeutics.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Discussion about the science behind the recent changes to the National Cholesterol Education Program (NCEP) cholesterol-lowering guidelines and novel therapeutic approaches in the management of patients...

Disordered coagulation may contribute to the pathogenesis of asthma.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Inflammatory mechanisms may lead to airway closure in patients with asthma. "In several clinical disorders, there are interactions between inflammation-dependent tissue injury and thrombin...

$6.95 million NIH contract awarded for RVAD development.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The Cleveland Clinic department of biomedical engineering and Kiyotaka Fukamachi, MD, PhD, have been awarded a $6.95 million contract from the National Heart, Lung and Blood Institute to develop and...

Cumulative dose of epirubicin can be related to cardiotoxicity.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The cumulative epirubicin dose - rather than high-dose paclitaxel - is associated with impaired cardiac function in breast cancer patients. According to a study from Italy, "The aim of the study was...

A simple technique helps introduce intracoronary shunts for off-pump CABG.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Introducing the intracoronary shunts in off-pump coronary artery bypass surgery can be facilitated by a new technique that utilizes a micro-bulldog clamp. "We describe a simple technique of...

Phase I trial initiated for thrombin inhibitor, ARC183.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Archemix Corp. and Nuvelo, Inc., (NUVO) announced the commencement of dosing in a phase I clinical trial of ARC183, an anti-thrombin aptamer that is being developed as an anticoagulant/anti-thrombotic...

Surgical instrumentation designed for closed-chest bypass surgery introduced.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Medtronic, Inc., (NYSE:MDT) introduced two versions of its widely used Medtronic Octopus Tissue Stabilizer, completing a new generation of surgical instrumentation designed to facilitate closed-chest...

Depression is common among patients with coronary artery disease.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Depression is common among patients with coronary artery disease. "High rates of depression have been reported in patients with coronary artery disease, and depression has been repeatedly shown to...

Elective sirolimus-eluting stents are effective.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Elective sirolimus-eluting stent (SES) implantation for left main (LM) stenoses disease was associated with no mortality and few major adverse events. According to a study from Netherlands, "The...

Systemic nitric oxide metabolites may play a role in human coronary circulation.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Systemic nitrate and nitrite (NOx) may play a complementary role on impaired coronary vasoregulation. According to recent research from Japan, "Several previous studies have suggested decreased...

apoE gene polymorphism affects triglycerides, not CAD risk, in white women <65.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers in Slovenia have determined that in women under age 65 in that country, the apolipoprotein E (apoE) gene polymorphism is associated with higher triglyceride levels, but not increased risk...

Overlapping stents are effective for long coronary lesions.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Study finds that stent overlapping is as effective as one long stent in long coronary lesions. According to a study from South Korea, "Intervention of long coronary lesions remains problematic, and...

Lipid-induced insulin secretion impairment reversed with malate analog.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Scientists have elucidated the biochemical mechanism of lipid-induced impairment of glucose-stimulated insulin secretion. According to a study from the United States, "Hyperlipidemia appears to...

Methods to reduce cardiovascular morbidity in type 2 diabetes outlined.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Scientists review methods for the reduction of cardiovascular morbidity and mortality in type 2 diabetes in a recent issue of the Journal of Endocrinological Investigation. According to a study...

PPAR agonists reduce risk of atherosclerosis in diabetic patients.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Peroxisome proliferator-activated receptor (PPAR) agonists reduce the risk of atherosclerosis in diabetic patients. "Drugs targeting both peroxisome proliferator-activated receptor-gamma...

Phase I clinical trial initiated for EP-2104R.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- EPIX Medical, Inc., (EPIX), a developer of pharmaceuticals for magnetic resonance imaging (MRI), has initiated its first human clinical trial of EP-2104R, an injectable MRI contrast agent which...

Characteristics are desribed for adhesion of microfabricated particles.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The adhesion of microfabricated particles on vascular endothelium has been analyzed. According to published research from Italy, "'Smart' drug delivery systems should be selective and effective to...

Formulation of oral heparin selected after successful clinical study.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Emisphere Technologies, Inc., (EMIS) has selected a soft-gelatin capsule formulation of unfractionated heparin (UFH), an antithrombotic/anticoagulant, that achieved clinically significant delivery of...

Antisense drug demonstrates significant durable reductions in cholesterol.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Isis Pharmaceuticals, Inc. (ISIS) has announced preliminary data from a phase 1 trial. The trial is demonstrating ISIS 301012 produced dose-dependent, rapid and prolonged reductions of its target,...

Drug development company reports second quarter financial results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- OXIS International, Inc., (OTCBB:OXIS) (Nouveau Marche:OXIS) announced financial results for the second quarter of 2004. For the second quarter ended June 30, 2004, the company reported revenues of...

Rare mutations can significantly increase risk factor for heart disease.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Certain rare gene mutations can contribute significantly to low levels of a beneficial form of cholesterol in the blood, researchers have found. Low levels of this cholesterol, known as high-density...

Duke University to evaluate 12-lead ambulatory heart monitoring system.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Recom Managed Systems, Inc. (RECM) and Duke Clinical Research Institute announced entering into a letter of intent to evaluate the performance of the Recom Model 100 ambulatory ECG (electrocardiogram)...

Safety review of endocarditis/bacteremia data for Cubicin completed.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Cubist Pharmaceuticals, Inc., (CBST) announced the completion of the third planned safety review of patients enrolled in Cubist's ongoing international phase III clinical trial examining the safety and...

Adiponectin may treat vascular disorders related to obesity.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Adiponectin may treat vascular disorders related to obesity. "Obesity is a risk factor for the development of cardiovascular diseases that are associated with impaired angiogenesis. Adiponectin is...

Mitochondrial genome mutations may be found in hypertensive individuals.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers find some coding region mutations that are associated with cardiovascular and renal pathologies. "Human essential hypertension (HTN), a polygenic, multifactorial, and highly...

Biotechnology company reports financial results for second quarter 2004.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Lipid Sciences, Inc., (LIPD) reported financial results for the second quarter and 6 months ended June 30, 2004. For the second quarter of 2004, the company reported a net loss of $3.6 million, or...

Cardiovascular diagnostics company receives $663K from exercise of warrants.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Hypertension Diagnostics, Inc., (HDII) announced that on August 6, 2004, HDI completed the issuance of 2,223,630 shares of common stock and 139,824 shares of Series A Preferred Stock to holders of...

Drug company attributes increased net losses to increased R&D expenses.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- DOV Pharmaceutical, Inc., (DOVP) announced results for the second quarter ending June 30, 2004. For the second quarter of 2004, the company reported a net loss of $8.3 million, or $0.43 per share,...

Electrophysiology company's revenues increase 53% year-over-year.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- EP MedSystems, Inc., (EPMD), a developer of electrophysiology (EP) products used to diagnose and treat certain types of cardiac rhythm disorders, announced financial results for the three months ended...

Healthcare company announces record revenue and income results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- ResMed Inc. (NYSE:RMD) announced record revenue and income results for the quarter and year ended June 30, 2004. Revenues for the June 30, 2004, quarter were $92.9 million, a 23% increase over the...

MedCath Corporation reports 27% increase in third quarter revenue.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- MedCath Corporation (MDTH) announced its operating results for its third quarter, which ended June 30, 2004. MedCath's net revenue increased 27.0% to $180.8 million in the third quarter of fiscal...

Oncology and cardiovascular products developer announces financial results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Neoprobe Corporation (OTCBB:NEOP) announced consolidated operating results for the second quarter of 2004. Second quarter results included revenues of $1.5 million compared to $1.9 million for the...

Pharmaceutical company announces second quarter 2004 financial results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Nuvelo, Inc., (NASDAQ:NUVO) announced results for the quarter ended June 30, 2004. Nuvelo incurred a net loss of $11.0 million or $0.34 per share for the 3 months ended June 30, 2004, and $28.6...

Pharmaceutical company reports second quarter 2004 results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Titan Pharmaceuticals, Inc. (TTP) announced financial results for the second quarter ended June 30, 2004. Net loss for the second quarter of 2004 was approximately $5.6 million, or $0.17 per share,...

Seattle takes steps atop Space Needle to fight heart disease.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Local Seattle, Washington, personalities hiked aroundt the 520-foot-high outer rim of the Space Needle to kick off the American Heart Association's Heart Walk "Halo Auction." The Space Needle...

Aerobic exercise dysfunction in HIV is potential link to physical disability.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Aerobic exercise dysfunction in HIV-infected persons is a potential link to physical disability. According to recent research published in the journal Physical Therapy, "Approximately 282,000...

High seroprevalence of hantavirus infection on Azuero peninsula of Panama.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A high seroprevalence of hantavirus infection was seen on the Azuero peninsula of Panama. According to published research from Panama, "The first outbreak of hantavirus pulmonary syndrome (HPS) in...